Robotic surgery for staging of serous papillary and clear cell carcinoma of the endometrium.
BACKGROUND
The feasibility of robotic staging for high-risk endometrial cancer is unclear.


METHODS
Retrospective review of papillary serous and clear cell endometrial cancer open staging (OS) and robotic staging (RS) cases (2009-2011) by two gynaecological oncologists.


RESULTS
There were 15 OS and 17 RS cases (no conversions). Age, uterine weight and body mass index were comparable, with more stage I RS cases. Operative time (172.5 vs 124.2 min, p =  0.0005), blood loss (71.9 vs 310.0 ml, p = 0.0002), hospital stay (5.4 vs 1.2  days, p = 0.0016) and lymphadenectomy yield (16.8 vs 10.2 nodes, p = 0.0041) were decreased for RS. Optimal cytoreduction rates (100% vs 93%, p = 0.2794), follow-up (19.9 vs 27.1 months, p = 0.2283) and recurrences (three vs five, p = 0.5395) were equivalent. Disease-free survival (54.5% vs 66.7%, p = 0.5302) and overall survival rates (81.8% vs 80.0%, p = 0.9075) were equivalent.


CONCLUSIONS
Robotic staging is feasible with minimal blood loss, a short operative time and recovery and good optimal cytoreduction rates.
Department of Gynecological Oncology, Northside Hospital, Atlanta, GA, USA.
Gerald A
GA
Feuer
Nisha
N
Lakhi
Andrew
A
Woo
Stephen S
SS
Salmieri
Matthew
M
Burrell
Eli
E
Serur
D000368:Aged; D000369:Aged, 80 and over; D002277:Carcinoma / Q000601:surgery*; D002291:Carcinoma, Papillary / Q000601:surgery*; D016889:Endometrial Neoplasms / Q000601:surgery*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging / Q000379:methods*; D012189:Retrospective Studies; D065287:Robotic Surgical Procedures / Q000379:methods*; D016896:Treatment Outcome
minimally invasive surgery; robotic surgery